title: [Dilingdan Decoction prevents renal interstitial fibrosis in a rat model of unilateral ureteral obstruction].
abstract: OBJECTIVE
  To investigate the preventive and therapeutic effects and the possible mechanisms of Dilingdan Decoction (DLDD), a compound Chinese herbal medicine, on rats with renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction (UUO).
  
  
  METHODS
  Sixty SD rats were randomly divided into sham-operated group, untreated group, enalapril-treated group and DLDD-treated group. Blood urea nitrogen (BUN), serum creatinine (SCr), urine protein quantization in 24 hours and pathological changes of the obstructed kidney were observed. The expressions of transforming growth factor-beta1 (TGF-beta1), alpha-smooth muscle actin (alpha-SMA), fibronectin (FN) and laminin (LN) were detected by immunohistochemical method and colored-multimedia pathological image analysis system.
  
  
  RESULTS
  Massive inflammatory infiltrates and collagen expression in renal interstitial in the untreated group were observed on the 7th day. Compared with the sham-operated group, percentages of area of TGF-beta1, alpha-SMA, FN and LN expressions in the untreated group were markedly increased (P<0.05), while the percentage of area of interstitial fibrosis was decreased in the DLDD-treated group as compared with the untreated group (P<0.05). On the 14th day, the percentages of area of TGF-beta1, alpha-SMA, FN and LN expressions were declined in two treated groups as compared with the untreated group (P<0.05), but had no statistical difference in biochemical indicators, including BUN, SCr and 24-hour urinary protein. On the 21st day, the level of SCr and the percentage of area of TGF-beta1 expression in the DLDD-treated group were lower than those of the enalapril-treated group (P<0.05).
  
  
  CONCLUSIONS
  DLDD can reduce the excretion of urinary protein and the degree of interstitial fibrosis, and significantly inhibit the expressions of TGF-beta1, alpha-SMA, FN and LN. DLDD is superior to enalapril in protecting renal function after long-time application in rats.
authors.affiliation: Department of Nephrology, the 85th Hospital of People's Liberation Army, Shanghai 200052, China. huanpp@hotmail.com
authors.forename: Hong-di
authors.initials: HD
authors.lastname: Huan
authors.forename: Jing-Hong
authors.initials: JH
authors.lastname: Zhang
authors.forename: Shi-Rong
authors.initials: SR
authors.lastname: Zheng
authors.forename: Wei-Wei
authors.initials: WW
authors.lastname: Meng
authors.forename: Jun-Li
authors.initials: JL
authors.lastname: Zhang
mesh_terms: D000199:Actins / Q000097:blood; D000818:Animals; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005353:Fibronectins; D008297:Male; D009395:Nephritis, Interstitial / Q000209:etiology / Q000517:prevention & control*; D009400:Nephrosclerosis / Q000209:etiology / Q000517:prevention & control*; D008517:Phytotherapy; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D053773:Transforming Growth Factor beta1 / Q000097:blood; D014517:Ureteral Obstruction / Q000150:complications*
chemical_list: D000199:Actins; D004365:Drugs, Chinese Herbal; D005353:Fibronectins; D053773:Transforming Growth Factor beta1; C498862:Acta2 protein, rat